Idaho § 37-128 SALE OF NEW DRUGS — REGULATIONS AND PROCEDURES

Idaho Statutes

§ 37-128 — SALE OF NEW DRUGS — REGULATIONS AND PROCEDURES

Idaho § 37-128

Title 37FOOD, DRUGS, AND OIL

Ch. 1IDAHO FOOD, DRUG AND COSMETIC ACT

This text of Idaho § 37-128 (SALE OF NEW DRUGS — REGULATIONS AND PROCEDURES) is published on Counsel Stack Legal Research, covering Idaho primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Idaho Code § 37-128 (2026).

Text

(a)No person shall sell, deliver, offer for sale, hold for sale or give away any new drug unless (1) an application with respect thereto has become effective under section 505 of the federal act, or (2) when not subject to the federal act unless such drug has been tested and has not been found to be unsafe for use under the conditions prescribed, recommended, or suggested in the labeling thereof, and prior to selling or offering for sale such drug, there has been filed with the director an application setting forth (a) full reports of investigations which have been made to show whether or not such drug is safe for use;

(b)a full list of the articles used as components of such drug;

(c)a full statement of the composition of such drug;

(d)a full description of the methods used in, and th

Free access — add to your briefcase to read the full text and ask questions with AI

(a) No person shall sell, deliver, offer for sale, hold for sale or give away any new drug unless (1) an application with respect thereto has become effective under section 505 of the federal act, or (2) when not subject to the federal act unless such drug has been tested and has not been found to be unsafe for use under the conditions prescribed, recommended, or suggested in the labeling thereof, and prior to selling or offering for sale such drug, there has been filed with the director an application setting forth (a) full reports of investigations which have been made to show whether or not such drug is safe for use; (b) a full list of the articles used as components of such drug; (c) a full statement of the composition of such drug; (d) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug; (e) such samples of such drugs and of the articles used as components thereof as the board may require; and (f) specimens of the labeling proposed to be used for such drug.
(b) An application provided for in subsection (a)(2) shall become effective on the sixtieth (60th) day after the filing thereof, except that if the director finds after due notice to the applicant and giving him an opportunity for a hearing, that the drug is not safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof, he shall, prior to the effective date of the application, issue an order refusing to permit the application to become effective.
(c) This section shall not apply–(1) to a drug intended solely for investigational use by experts qualified by scientific training and experience to investigate the safety in drugs provided the drug is plainly labeled "For investigational use only"; or (2) to a drug sold in this state at any time prior to the enactment of this act or introduced into interstate commerce at any time prior to the enactment of the federal act; or (3) to any drug which is licensed under the Virus, Serum, and Toxin Act of July 1, 1902 (U.S.C. 1934 ed. title 42, Chap. 4).
(d) An order refusing to permit an application under this section to become effective may be revoked by the director.